Chi Kei Wong
Director/Board Member at JACOBSON PHARMA CORPORATION LIMITED
Chi Kei Wong active positions
| Companies | Position | Start | End |
|---|---|---|---|
| JACOBSON PHARMA CORPORATION LIMITED | Director/Board Member | 2017-11-30 | - |
| Independent Dir/Board Member | 2017-11-30 | 2022-01-13 | |
| University of Hong Kong | Corporate Officer/Principal | - | - |
Career history of Chi Kei Wong
Former positions of Chi Kei Wong
| Companies | Position | Start | End |
|---|---|---|---|
| Pharmacy & Poisons Board of Hong Kong | Corporate Officer/Principal | 2018-12-31 | 2020-12-31 |
| UCL School of Pharmacy | Corporate Officer/Principal | 2001-12-31 | 2017-12-31 |
| Pharmacy & Poisons Board of Hong Kong | Corporate Officer/Principal | 2011-12-31 | 2014-12-31 |
| UCL Institute of Child Health | Corporate Officer/Principal | 2001-12-31 | 2010-12-31 |
Great Ormond Street Hospital Children's Charity
 Great Ormond Street Hospital Children's Charity Investment Trusts/Mutual FundsMiscellaneous Great Ormond Street Hospital Children's Charity is a non-profit organization which engages in fundraising and charitable activities to help children's who have medical needs. The company was founded in 1998 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 2001-12-31 | 2010-12-31 |
| University of London | Corporate Officer/Principal | 2001-12-31 | 2010-12-31 |
Therakind Ltd.
 Therakind Ltd. Pharmaceuticals: MajorHealth Technology Therakind Ltd. is a British specialty pharmaceutical company that develops niche medicines for difficult-to-treat markets, including paediatric and geriatric patient groups. The private company is based in London, UK. The company's proprietary pipeline focuses on improving medicine adherence through more patient-friendly dosing options. Therakind has a strong track record in the research and development of innovative medicines and drug delivery systems designed specifically for difficult-to-treat patient groups. The company's third product, Jylamvo, has gained regulatory approval. The company was founded in 2006 by Chi Kei Wong, and the CEO is Susan Esther Conroy. | Founder | 2006-12-31 | - |
Training of Chi Kei Wong
| Manchester Medical School | Doctorate Degree |
Statistics
International
| United Kingdom | 7 |
| Hong Kong | 3 |
| Cayman Islands | 2 |
Operational
| Corporate Officer/Principal | 7 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 3 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| JACOBSON PHARMA CORPORATION LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
| Pharmacy & Poisons Board of Hong Kong | |
| UCL Institute of Child Health | |
Great Ormond Street Hospital Children's Charity
Great Ormond Street Hospital Children's Charity Investment Trusts/Mutual FundsMiscellaneous Great Ormond Street Hospital Children's Charity is a non-profit organization which engages in fundraising and charitable activities to help children's who have medical needs. The company was founded in 1998 and is headquartered in London, the United Kingdom. | Miscellaneous |
Therakind Ltd.
Therakind Ltd. Pharmaceuticals: MajorHealth Technology Therakind Ltd. is a British specialty pharmaceutical company that develops niche medicines for difficult-to-treat markets, including paediatric and geriatric patient groups. The private company is based in London, UK. The company's proprietary pipeline focuses on improving medicine adherence through more patient-friendly dosing options. Therakind has a strong track record in the research and development of innovative medicines and drug delivery systems designed specifically for difficult-to-treat patient groups. The company's third product, Jylamvo, has gained regulatory approval. The company was founded in 2006 by Chi Kei Wong, and the CEO is Susan Esther Conroy. | Health Technology |
- Stock Market
- Insiders
- Chi Kei Wong
- Experience
